Browse Category

NASDAQ:NAMS News 5 January 2026

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

NewAmsterdam Pharma stock slides on insider sale notices — what investors watch next for NAMS

New York, Jan 5, 2026, 15:21 EST — Regular session Shares of NewAmsterdam Pharma Company N.V. fell about 5% to $33.42 in afternoon trading on Monday. The Nasdaq-listed stock hit an intraday low of $32.68 after opening at $35.15. The move followed two Form 144 filings that signaled planned sales by company affiliates. In smaller biotech names, even routine insider…

Stock Market Today

  • Bharti Hexacom Stock Falls 18% Despite Strong 25% ROE and Robust Earnings Growth
    January 28, 2026, 9:53 PM EST. Bharti Hexacom Limited's stock has dropped 18% over three months, yet its fundamentals remain strong. The company's return on equity (ROE), a measure of profitability relative to shareholder investments, stands at 25%, well above the industry average of 13%. This indicates efficient capital use by management. Over the past five years, Bharti Hexacom achieved net income growth of 28%, outperforming the industry average of 5.3%. Such growth and profit retention suggest potential for continued expansion. Investors weighing the stock should consider if this strong earnings momentum is already reflected in the current share price before deciding on its future outlook.
Go toTop